About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
SOPHiA GENETICS SA (SOPH) Insider Trading
63 open-market trades reported since Jun 15, 2026: 0 purchases worth $0 and 63 sales worth $3.99M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Jurgi Camblong | Executive Chair | 0 | $0 | 15 | $2.15M |
| Philippe Menu | Chief Medical Officer | 0 | $0 | 10 | $364K |
| Zhenyu Xu | Chief Scientific Officer | 0 | $0 | 14 | $698K |
| Ross Muken | CEO | 0 | $0 | 4 | $137K |
| Van Well Daan | General Counsel | 0 | $0 | 2 | $97K |
| Abhimanyu Verma | CTO | 0 | $0 | 7 | $266K |
| Manuela Valente | Chief People Officer | 0 | $0 | 3 | $135K |
| George Cardoza | CFO | 0 | $0 | 4 | $32K |
| Kevin Puylaert | Chief Sales Officer | 0 | $0 | 2 | $3K |
| Kathy L. Hibbs | Director | 0 | $0 | 2 | $105K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 14 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $62K | |
| Oct 14 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $36K | |
| Oct 14 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $29K | |
| Oct 7 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $327K | |
| Oct 7 | Ross MukenCEO | ▼ SELL10b5-1 | $80K | |
| Oct 7 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $60K | |
| Oct 7 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $60K | |
| Oct 7 | Van Well DaanGeneral Counsel | ▼ SELL10b5-1 | $50K | |
| Oct 7 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $43K | |
| Oct 7 | Manuela ValenteChief People Officer | ▼ SELL10b5-1 | $34K | |
| Oct 7 | George CardozaCFO | ▼ SELL10b5-1 | $13K | |
| Oct 7 | Kevin PuylaertChief Sales Officer | ▼ SELL | $2K | |
| Sep 22 | George CardozaCFO | ▼ SELL10b5-1 | $6K | |
| Sep 22 | Ross MukenCEO | ▼ SELL10b5-1 | $4K | |
| Sep 16 | Philippe MenuChief Medical Officer | ▼ SELL | $39K | |
| Sep 16 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $32K | |
| Sep 14 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $65K | |
| Sep 14 | Van Well DaanGeneral Counsel | ▼ SELL10b5-1 | $47K | |
| Sep 10 | Kathy L. HibbsDirector | ▼ SELL10b5-1 | $51K | |
| Aug 31 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $89K | |
| Aug 26 | Kathy L. HibbsDirector | ▼ SELL10b5-1 | $54K | |
| Aug 26 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $44K | |
| Aug 26 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $43K | |
| Aug 26 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $41K | |
| Aug 21 | Manuela ValenteChief People Officer | ▼ SELL10b5-1 | $79K | |
| Aug 21 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $79K | |
| Aug 21 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $45K | |
| Aug 21 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $39K | |
| Aug 14 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $38K | |
| Aug 14 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $30K | |
| Aug 10 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $145K | |
| Aug 10 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $65K | |
| Aug 10 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $38K | |
| Aug 7 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $124K | |
| Aug 7 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $21K | |
| Aug 5 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $138K | |
| Aug 5 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $69K | |
| Aug 5 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $35K | |
| Jul 28 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $28K | |
| Jul 22 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $153K | |
| Jul 22 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $133K | |
| Jul 14 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $48K | |
| Jul 14 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $29K | |
| Jul 14 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $23K | |
| Jul 8 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $93K | |
| Jul 7 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $118K | |
| Jul 7 | Ross MukenCEO | ▼ SELL10b5-1 | $51K | |
| Jul 7 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $38K | |
| Jul 7 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $38K | |
| Jul 7 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $27K | |
| Jul 7 | Manuela ValenteChief People Officer | ▼ SELL10b5-1 | $21K | |
| Jul 7 | George CardozaCFO | ▼ SELL10b5-1 | $8K | |
| Jul 7 | Kevin PuylaertChief Sales Officer | ▼ SELL | $1K | |
| Jul 1 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $399K | |
| Jul 1 | Jurgi CamblongExecutive Chair | ▼ SELL10b5-1 | $108K | |
| Jun 29 | Jurgi CamblongCEO | ▼ SELL10b5-1 | $290K | |
| Jun 29 | Jurgi CamblongCEO | ▼ SELL10b5-1 | $8K | |
| Jun 26 | Abhimanyu VermaCTO | ▼ SELL10b5-1 | $38K | |
| Jun 26 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $28K | |
| Jun 23 | George CardozaCFO | ▼ SELL10b5-1 | $4K | |
| Jun 23 | Ross MukenPresident | ▼ SELL10b5-1 | $2K | |
| Jun 17 | Zhenyu XuChief Scientific Officer | ▼ SELL10b5-1 | $20K | |
| Jun 15 | Philippe MenuChief Medical Officer | ▼ SELL10b5-1 | $25K |